Clinical Trial Update: A Phase I/III Clinical Study of TPX-114 for the Treatment of Full-Thickness Rotator Cuff Tear [Phase 3]

View source ↗

Summary

A Phase 3 clinical study of TPX-114 for full-thickness rotator cuff tear has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Injuries

Drugs mentioned

• TPX-114

Snippet

Sponsor: Tego Science, Inc. | Conditions: Rotator Cuff Injuries | Phase 3 | Status: COMPLETED